Growth Metrics

Scholar Rock Holding (SRRK) Shares Outstanding (Diluted Average) (2020 - 2026)

Scholar Rock Holding's quarterly Shares Outstanding (Diluted Average) came in at $127.3 million in Q1 2026, up 13.8% year-on-year from $111.8 million in Q1 2025, and up 10.96% quarter-over-quarter from $114.7 million in Q4 2025.

Scholar Rock Holding has reported Shares Outstanding (Diluted Average) for 7 years, with the latest figure at $127.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 13.8% year-over-year to $127.3 million; the trailing twelve-month figure through Mar 2026 stood at $127.3 million (up 13.8% YoY), and the FY2025 full-year result was $114.7 million, up 14.89% from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 stood at $127.3 million, up from $114.7 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $127.3 million in Q1 2026, with the low at $37.5 million in Q1 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $87.1 million, with a median of $95.9 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Diluted Average) climbed 2.96% in 2022 and surged 112.54% in 2023.
  • Tracing SRRK's Shares Outstanding (Diluted Average) over 5 years: stood at $59.6 million in 2022, then soared by 39.82% to $83.3 million in 2023, then climbed by 19.79% to $99.8 million in 2024, then climbed by 14.89% to $114.7 million in 2025, then advanced by 10.96% to $127.3 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $127.3 million (Q1 2026), $114.7 million (Q4 2025), and $112.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 810.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 256.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 138.23 Mn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - 127.28 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 127.28 Mn
Dec 31, 2025 114.70 Mn
Sep 30, 2025 112.76 Mn
Jun 30, 2025 112.27 Mn
Mar 31, 2025 111.84 Mn
Dec 31, 2024 99.84 Mn
Sep 30, 2024 96.59 Mn
Jun 30, 2024 96.81 Mn
Mar 31, 2024 95.89 Mn
Dec 31, 2023 83.35 Mn
Sep 30, 2023 80.12 Mn
Jun 30, 2023 79.87 Mn
Mar 31, 2023 79.61 Mn
Dec 31, 2022 59.61 Mn
Sep 30, 2022 52.96 Mn
Jun 30, 2022 39.55 Mn
Mar 31, 2022 37.46 Mn
Dec 31, 2021 36.71 Mn
Sep 30, 2021 36.55 Mn
Jun 30, 2021 36.48 Mn
Mar 31, 2021 36.38 Mn
Dec 31, 2020 30.73 Mn
Sep 30, 2020 29.67 Mn